,
Frank S. David

Frank S. David’s Followers (4)

member photo
member photo
member photo
member photo

Frank hasn't connected with their friends on Goodreads, yet.


Frank S. David

Goodreads Author


Website

Twitter

Genre

Member Since
November 2022


I'm a biopharma advisor at Pharmagellan who specializes in R&D strategy.

As an author, I want to help experts in and around the drug industry interpret clinical results and estimate the value of drugs in development.

Read my book ratings for my must-read recs for biopharma pros and newbies.

Please sign up for my free biotech newsletter on the Pharmagellan website!
...more

To ask Frank S. David questions, please sign up.

Popular Answered Questions

Frank S. David I'm trying to get current on articles I missed in Nature Reviews Drug Discovery. There are always interesting pieces on biopharma R&D strategy there, …moreI'm trying to get current on articles I missed in Nature Reviews Drug Discovery. There are always interesting pieces on biopharma R&D strategy there, and I have trouble keeping up! I'm also reading several books about market research, because I'm trying to level up my skills in surveying physicians about R&D-stage drug candidates.(less)
Frank S. David Right now I'm mainly working on writing my free newsletter about biotech trials and R&D strategy. (Here's a recent issue, about red flags in biotech P…moreRight now I'm mainly working on writing my free newsletter about biotech trials and R&D strategy. (Here's a recent issue, about red flags in biotech PR: https://mailchi.mp/pharmagellan/btd-1...) Please sign up on the Pharmagellan website if you're interested!(less)
Average rating: 4.4 · 127 ratings · 8 reviews · 2 distinct worksSimilar authors
The Pharmagellan Guide to B...

by
4.33 avg rating — 76 ratings2 editions
Rate this book
Clear rating
The Pharmagellan Guide to A...

4.51 avg rating — 51 ratings2 editions
Rate this book
Clear rating

* Note: these are all the books on Goodreads for this author. To add more, click here.

No comments have been added yet.